Switching to ABRILADA

Not actual patients.

people in car
people in car

If you are switching to ABRILADA from Humira® (adalimumab), it is important to keep in mind that

FDA process icon

You are receiving an FDA-approved biosimilar that was approved through a strict review process. ABRILADA was approved for all eligible indications of Humira*

interchangeable biosimilar icon

ABRILADA works the same way and is dosed the same way as Humira

pen and syringe icons

ABRILADA has the same dosing as Humira and is provided in a pen and prefilled syringe, similar to the administration of Humira

*ABRILADA is approved for all indications of Humira except for pediatric UC, adolescent HS, and pediatric UV.

You can expect similar treatment outcomes with ABRILADA

  • Individual results may vary
  • In clinical studies, ABRILADA showed no clinically meaningful differences in safety and efficacy from Humira
  • ABRILADA is interchangeable with Humira. Keep in mind this means that ABRILADA can be substituted for Humira at the specialty pharmacy, depending on state pharmacy laws, without having to consult your physician. Your specialty pharmacist may discuss this substitution with you

Questions about ABRILADA?

Access a variety of educational materials to support you through your treatment journey

Learn more